September 29, 2025

Blood-brain barrier remains resilient in widely used Alzheimer’s disease model, challenging previous assumptions

September 29, 2025 / Research update / InnovateMed Author / alzheimer disease

by Texas Tech University edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The LMD6 laser microdissection system was used to selectively isolate distinct regions within the brain hemispheres of young and aged Tg2576 AD mice following Amytracker 680 injection. Credit: Fluids and Barriers of the CNS (2025). DOI: 10.1186/s12987-025-00685-2 A team of scientists at Texas Tech University Health […]

Blood-brain barrier remains resilient in widely used Alzheimer’s disease model, challenging previous assumptions Read More »

Novel immunotherapy targets common cancer mutation, offering hope for lung and prostate cancer patients

September 29, 2025 / Research update / InnovateMed Author / prostate cancer

by University of Oslo edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Schematic illustration of the Wnt–β-catenin signaling pathway with or without exon 3-mutated β-catenin. Credit: Nature Immunology (2025). DOI: 10.1038/s41590-025-02252-1 Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such

Novel immunotherapy targets common cancer mutation, offering hope for lung and prostate cancer patients Read More »

Designer biobots made from human lung cells

September 29, 2025 / Research update / InnovateMed Author / human lung cells

A brand-new engineering approach to generate “designer” biological robots using human lung cells is underway in Carnegie Mellon University’s Ren lab. Referred to as AggreBots, these microscale living robots may one day be able to traverse through the body’s complex environments to deliver desired therapeutic or mechanical interventions, once greater control is achieved over their

Designer biobots made from human lung cells Read More »

Older adults can bounce back to thriving health, study finds

September 29, 2025 / Research update / InnovateMed Author / thriving health

by University of Toronto edited by Robert Egan Editors’ notes Credit: Kampus Production from Pexels A new Canadian study is offering a powerful message to older adults and those who care for them: it’s never too late to bounce back. Researchers at the University of Toronto have found that nearly one in four older adults age 60

Older adults can bounce back to thriving health, study finds Read More »

Obesity Treatment: Study Backs Dual-Drug Strategy

September 29, 2025 / Research update / InnovateMed Author / obesity treatment

Teresa Santos; Ilana Polistchuck September 26, 2025 Projections from the World Obesity Federation estimate that the number of adults living with obesity will rise from 810 million in 2020 to 1.53 billion by 2035. Among the strategies to address this challenge are anti-obesity medications such as sibutramine and topiramate. The combination of these two drugs has been

Obesity Treatment: Study Backs Dual-Drug Strategy Read More »

Oral bacteria linked to Parkinson’s via the gut-brain axis

September 29, 2025 / Research update / InnovateMed Author / oral bacteria, parkinson

by Pohang University of Science and Technology edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Diagram of Metabolite Accumulation in the Brain and Parkinson’s disease Induction Following Oral Bacteria Colonization in the Gut. Credit: POSTECH Korean researchers have uncovered compelling evidence that oral bacteria, once colonized in the gut, can affect neurons in the brain and

Oral bacteria linked to Parkinson’s via the gut-brain axis Read More »

Existing drug slows progression of type 1 diabetes in newly diagnosed

September 29, 2025 / Research update / InnovateMed Author / type 1 diabetes

By Paul McClure September 27, 2025 Facebook Twitter LinkedIn Reddit Email An old drug may be repurposed to modify the course of type 1 diabetes after diagnosis Depositphotos View 1 Images An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for

Existing drug slows progression of type 1 diabetes in newly diagnosed Read More »

Hospitals’ next site-neutral battle

September 29, 2025 / News update / InnovateMed Author / site neutral battle

By Maya Goldman An illustration of a heart rate monitor with dollar signs and line graphs Illustration: Sarah Grillo / Axios Hospitals appear to be on a collision course with the Trump administration over its push to change the way Medicare pays them for certain outpatient procedures. Why it matters: Health systems stand to lose billions of

Hospitals’ next site-neutral battle Read More »

Are Probiotics Helpful in Treating Cardiovascular Issues?

September 29, 2025 / Clinical Practice / InnovateMed Author / cardiovascular disesae, probiotics

As a primary care doctor, you’re often the first clinician that patients trust to discuss cardiac issues. Not only can you assess cardiac symptoms, order diagnostic tests, and refer your patients to a cardiologist, but you can also use this front-line role to discuss other ways to treat cardiac concerns. During your consultations, you will

Are Probiotics Helpful in Treating Cardiovascular Issues? Read More »

Reducing MMI Dose Pre-Stop Cuts Relapse in Graves Disease

September 29, 2025 / Clinical Practice / InnovateMed Author / graves disease

SCOTTSDALE, AZ — In patients with Graves disease, prescribing a lower maintenance dose of methimazole (MMI) before discontinuing the drug is associated with significantly higher rates of remission, compared with a higher dose, according to a new study presented at the 2025 American Thyroid Association Annual Meeting. “If further research confirms this association, these findings could contribute to

Reducing MMI Dose Pre-Stop Cuts Relapse in Graves Disease Read More »